Sort by
Refine Your Search
-
mechanical parts, moving vehicles, electrical current, working on scaffolding and high places, or exposure to chemicals). Physical Requirements and Level of Frequency that may be required Nearly Continuously
-
proximity to moving mechanical parts, moving vehicles, electrical current, working on scaffolding and high places, or exposure to chemicals). Physical Requirements and Level of Frequency that may be required
-
of mechanism-based cellular assays. Specific cellular and molecular biology skills required include DNA/RNA isolation, cDNA cloning, PCR, qRT-PCR, mammalian cell culture (both primary cells and cell lines
-
University of Utah is actively seeking an individual to conduct research on the disease mechanisms underlying inherited hearing loss and the cell biology of hair cells, employing various approaches in mouse
-
exposure to oils or other cutting fluids), hazards (includes a variety of physical conditions, such as proximity to moving mechanical parts, moving vehicles, electrical current, working on scaffolding and
-
, oils (there is air or skin exposure to oils or other cutting fluids), hazards (includes a variety of physical conditions, such as proximity to moving mechanical parts, moving vehicles, electrical current
-
conditions, such as proximity to moving mechanical parts, moving vehicles, electrical current, working on scaffolding and high places, or exposure to chemicals). Physical Requirements and Level of Frequency
-
systems and operations, mechanical, electrical, and plumbing, interior design, safety coordination, and demonstrated knowledge of custodial activities. Preferences Bachelor’s degree in Business, Facilities
-
on more than 7 million individuals. The Division of Gastroenterology and its current faculty are highly invested in clinical and translational research. Currently, our program is comprised of 11 research
-
glaucoma patients. This research aims to help better understand genotype-directed disease mechanisms, identify causal pathways and targets, and develop novel therapies to halt blinding eye diseases